WallStSmart
TLX

Telix Pharmaceuticals Limited

NASDAQ: TLX · HEALTHCARE · BIOTECHNOLOGY

$10.43
-0.10% today

Updated 2026-04-29

Market cap
$3.53B
P/E ratio
P/S ratio
4.40x
EPS (TTM)
$-0.02
Dividend yield
52W range
$6 – $19
Volume
0.3M

Telix Pharmaceuticals Limited (TLX) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item199920002011201320142015201620172018201920202021202220232024
Total assets$9.39M$11.78M$18.54M$17.73M$17.81M$18.61M$51.09M$76.71M$102.61M$157.82M$109.81M$260.59M$398.30M$1.52B
Cash & equivalents
Current assets$3.05M$6.73M$6.56M$7.05M$8.11M$8.73M$49.55M$35.86M$58.68M$93.63M$47.54M$173.23M$224.85M$918.56M
Total liabilities$352000.00$23.24M$17.04M$19.91M$18.03M$20.38M$1.80M$23.80M$31.88M$78.81M$106.17M$175.35M$249.39M$948.22M
Current liabilities$352000.00$17.88M$12.53M$7.44M$11.49M$14.26M$1.47M$8.24M$10.63M$19.96M$37.98M$85.56M$157.41M$330.91M
Long-term debt$95000.00$3.31M$8.21M$551.82M
Shareholder equity
Retained earnings$-6.08M$-16.71M$-24.78M$-31.62M$-33.08M$-6.38M$-20.21M$-48.07M$-92.96M$-173.47M$-272.81M$-263.67M$-212.96M
Accounts receivable$55000.00$2.39M$3.25M$3.96M$4.33M$488831.00$8.97M$13.01M$14.19M$20.84M$31.14M$79.53M$158.99M
Inventory$2.83M$2.53M$2.11M$2.57M$2.63M$297220.00$642525.00$542000.00$633000.00$3.45M$5.77M$17.31M$38.14M
Goodwill$732493.00$745505.00$865495.00$1.02M$1.03M$332489.00$3.14M$4.22M$4.22M$4.10M$5.52M$4.85M$106.65M